BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34878724)

  • 1. Carboxymethyl chitosan bounded iron oxide nanoparticles and gamma-irradiated avian influenza subtype H9N2 vaccine to development of immunity on mouse and chicken.
    Motamedi-Sedeh F; Saboorizadeh A; Khalili I; Sharbatdaran M; Wijewardana V; Arbabi A
    Vet Med Sci; 2022 Mar; 8(2):626-634. PubMed ID: 34878724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Whole Gamma Irradiated Avian Influenza Subtype H9N2 Virus Vaccine Using Trehalose and Optimization of Vaccination Regime on Broiler Chicken.
    Motamedi Sedeh F; Khalili I; Wijewardana V; Unger H; Shawrang P; Behgar M; Moosavi SM; Arbabi A; Hosseini SM
    Front Vet Sci; 2022; 9():907369. PubMed ID: 35903140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antigen conservation and inactivation of gamma-irradiated avian influenza virus subtype H9N2.
    Salehi B; Motamedi-Sedeh F; Madadgar O; Khalili I; Ghalyan Chi Langroudi A; Unger H; Wijewardana V
    Acta Microbiol Immunol Hung; 2018 Jun; 65(2):163-171. PubMed ID: 29685054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine.
    Alizadeh M; Raj S; Shojadoost B; Matsuyama-Kato A; Boodhoo N; Abdelaziz K; Sharif S
    Vaccine; 2023 Nov; 41(48):7281-7289. PubMed ID: 37923694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and immunological evaluation of inactivated avian influenza virus vaccine encapsulated in chitosan nanoparticles.
    Mohamed SH; Arafa AS; Mady WH; Fahmy HA; Omer LM; Morsi RE
    Biologicals; 2018 Jan; 51():46-53. PubMed ID: 29126666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.
    Sun H; Fei L; Zhu B; Shi M
    BMC Vet Res; 2020 Nov; 16(1):427. PubMed ID: 33160337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles.
    Khalili I; Ghadimipour R; Sadigh Eteghad S; Fathi Najafi M; Ebrahimi MM; Godsian N; Sefidi Heris Y; Khalili MT
    Jundishapur J Microbiol; 2015 Dec; 8(12):e27035. PubMed ID: 26865942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
    Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2.
    Rahman MM; Uyangaa E; Han YW; Kim SB; Kim JH; Choi JY; Yoo DJ; Hong JT; Han SB; Kim B; Kim K; Eo SK
    Vet Microbiol; 2011 Dec; 154(1-2):140-51. PubMed ID: 21764226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced infection of avian influenza virus H9N2 with infectious laryngeotracheitis vaccination in chickens.
    Arafat N; Eladl AH; Marghani BH; Saif MA; El-Shafei RA
    Vet Microbiol; 2018 Jun; 219():8-16. PubMed ID: 29778208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an inactivated influenza vaccine adjuvanted with Toll-like receptor ligands against transmission of H9N2 avian influenza virus in chickens.
    Raj S; Alizadeh M; Matsuyama-Kato A; Boodhoo N; Denis MS; Nagy É; Mubareka S; Karimi K; Behboudi S; Sharif S
    Vet Immunol Immunopathol; 2024 Feb; 268():110715. PubMed ID: 38219434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and pathological effects of vitamin E with Fetomune Plus
    Awadin WF; Eladl AH; El-Shafei RA; El-Adl MA; Ali HS
    Vet Microbiol; 2019 Apr; 231():24-32. PubMed ID: 30955817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvanted quaternized chitosan composite aluminum nanoparticles-based vaccine formulation promotes immune responses in chickens.
    Liu J; Guo S; Jin Z; Zhao K
    Vaccine; 2023 May; 41(18):2982-2989. PubMed ID: 37032226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
    Sun Z; Wang Q; Li G; Li J; Chen S; Qin T; Ma H; Peng D; Liu X
    Microbiol Spectr; 2021 Oct; 9(2):e0068721. PubMed ID: 34585985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of key immune protection factors in H9N2 avian influenza viruses infected and immunized specific pathogen-free chicken.
    Dai M; Li S; Keyi Shi ; Sun H; Zhao L; Deshui Yu ; Liao J; Xu C; Liao M
    Poult Sci; 2021 Jan; 100(1):39-46. PubMed ID: 33357705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.